Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Bristol-Myers Squibb (NY: BMY ) 50.76 +0.75 (+1.49%) Streaming Delayed Price Updated: 2:19 PM EDT, Sep 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 8,134,757 Open 50.01 Bid (Size) 50.75 (6) Ask (Size) 50.76 (3) Prev. Close 50.01 Today's Range 49.81 - 50.99 52wk Range 39.35 - 59.28 Shares Outstanding 2,222,113,553 Dividend Yield 4.49% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 10 Health Care Stocks With Whale Alerts In Today's Session September 23, 2024 Via Benzinga NYSE:BMY Shows Potential for a Breakout. September 23, 2024 A technical analysis of BRISTOL-MYERS SQUIBB CO (NYSE:BMY) shows it may be setting up for a breakout. Via Chartmill Performance YTD -3.80% -3.80% 1 Month +5.21% +5.21% 3 Month +20.19% +20.19% 6 Month -2.86% -2.86% 1 Year -14.21% -14.21% More News Read More Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years September 20, 2024 Via Benzinga Exposures Product Safety Edgewise Catapults On Surprise Victory In Cardiomyopathy; Cytokinetics Shares Dip September 19, 2024 Via Investor's Business Daily 2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure? September 19, 2024 Via Investor's Business Daily What Analysts Are Saying About Bristol-Myers Squibb Stock September 16, 2024 Via Benzinga Current Report: Bristol-Meyers Squibb (BMY) September 16, 2024 Via Talk Markets Bristol Myers Squibb Presents Data For Multiple Sclerosis Drug Zeposia, Shows Long-Term Efficacy September 18, 2024 Via Benzinga New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis September 18, 2024 From Bristol Myers Squibb Via Business Wire 3 High-Yield Dividend Stocks Down by More Than 39% to Buy Now and Hold at Least a Decade September 16, 2024 Via The Motley Fool Merck Scores Two Key Victories With Keytruda In Women's Cancers September 15, 2024 Via Investor's Business Daily Bristol Myers Squibb Presents Landmark 10-Year Follow-Up Data from CheckMate -067 Which Showed Continued Durable Long-Term Survival Benefit with Opdivo® plus Yervoy® in Advanced Melanoma September 15, 2024 From Bristol Myers Squibb Via Business Wire Got $200? 2 Healthcare Stocks to Buy and Hold Forever September 14, 2024 Via The Motley Fool Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Via Talk Markets Topics ETFs Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024 September 12, 2024 From Bristol Myers Squibb Via Business Wire Bristol Myers Squibb Announces Dividend September 10, 2024 From Bristol Myers Squibb Via Business Wire Bernie Sanders Says If You're Poor In America You'll Live 10-15 Years Less: 'Anybody Else See A Problem With That?' September 09, 2024 Via Benzinga Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst September 09, 2024 Via Benzinga Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms September 09, 2024 From Bristol Myers Squibb Via Business Wire 2 Unstoppable Dividend Growth Stocks You Can Buy Now With $100 September 08, 2024 Via The Motley Fool FDA Battles Backlog of Drug Factory Inspections Since COVID-19 September 06, 2024 Via Benzinga Exposures Product Safety Bristol Myers Squibb Employees to Relay Nearly 3,000 Miles Cross-Country Aspiring to Raise Over $1 Million for the V Foundation for Cancer Research September 06, 2024 From Bristol Myers Squibb Via Business Wire Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs September 03, 2024 Via Benzinga Topics Economy Exposures Interest Rates 2 Reasons Bristol Myers Squibb Stock Could Be a Bargain, Down 34% From Its All-Time High September 02, 2024 Via The Motley Fool 2 No-Brainer Large-Cap Stocks to Buy With $500 Right Now September 01, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
